Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04599 | 33568418 | BMJ Open Gastroenterol | Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. | 2021 | Details |
| A04600 | 33567710 | Int J Environ Res Public Health | Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date. | 2021 | Details |
| A04601 | 33567666 | Biomolecules | Signaling Nodes Associated with Endoplasmic Reticulum Stress during NAFLD Progression. | 2021 | Details |
| A04602 | 33567543 | Nutrients | Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia. | 2021 | Details |
| A04604 | 33566371 | FASEB J | NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response. | 2021 | Details |
| A04605 | 33566044 | Food Funct | Plant sterol ester of α-linolenic acid ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice: association with regulating mitochondrial dysfunction and oxidative stress via activating AMPK signaling. | 2021 | Details |
| A04606 | 33565643 | Aliment Pharmacol Ther | Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis. | 2021 | Details |
| A04608 | 33564868 | Am J Clin Nutr | Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study. | 2021 | Details |
| A04609 | 33564655 | Clin Nutr Res | Effect of Chlorella vulgaris on Liver Function Biomarkers: a Systematic Review and Meta-Analysis. | 2021 | Details |
| A04610 | 33564654 | Clin Nutr Res | The Effects of Nigella sativa Supplementation on Liver Enzymes Levels: a Systematic Review and Meta-analysis of Randomized Controlled Trials. | 2021 | Details |
| A04611 | 33564651 | Clin Nutr Res | Probiotic Yogurt Fortified with Vitamin D Can Improve Glycemic Status in Non-Alcoholic Fatty Liver Disease Patients: a Randomized Clinical Trial. | 2021 | Details |
| A04612 | 33564251 | Diabetes Metab Syndr Obes | A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China. | 2021 | Details |
| A04613 | 33562473 | Biology (Basel) | Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04614 | 33562458 | Pharmaceuticals (Basel) | The Current and Potential Therapeutic Use of Metformin-The Good Old Drug. | 2021 | Details |
| A04615 | 33562284 | J Clin Med | Metabolic Imaging in Non-Alcoholic Fatty Liver Disease: Applications of Magnetic Resonance Spectroscopy. | 2021 | Details |
| A04616 | 33561928 | Ultrasonography | Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography. | 2020 | Details |
| A04617 | 33561650 | Biomed Pharmacother | The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD. | 2021 | Details |
| A04618 | 33561256 | J Nutr | Dietary Fruit and Vegetable Supplementation Suppresses Diet-Induced Atherosclerosis in LDL Receptor Knockout Mice. | 2021 | Details |
| A04619 | 33560577 | Mol Nutr Food Res | Three Novel Dietary Phenolic Compounds from Pickled Raphanus Sativus L. Inhibit Lipid Accumulation in Obese Mice by Modulating the Gut Microbiota Composition. | 2021 | Details |
| A04620 | 33560053 | J Hypertens | Fatty liver index and left ventricular mass: prospective associations from two independent cohorts. | 2021 | Details |
| A04621 | 33559592 | Dtsch Arztebl Int | Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A04622 | 33559403 | Pediatr Obes | Longitudinal associations of total and trunk fat in childhood and adolescence and risk of hepatic steatosis at 24 years. | 2021 | Details |
| A04623 | 33559369 | Mol Nutr Food Res | Black Current Anthocyanins Improve Lipid Metabolism and Modulate Gut Microbiota in High-Fat Diet-Induced Obese Mice. | 2021 | Details |
| A04624 | 33559089 | Dig Dis Sci | Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults. | 2021 | Details |
| A04625 | 33559024 | Biol Trace Elem Res | Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity. | 2021 | Details |
| A04626 | 33558594 | Sci Rep | Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease. | 2021 | Details |
| A04627 | 33558081 | Mol Genet Metab | US-FLI score - Is it possible to predict the steatosis grade with an ultrasonographic score? | 2021 | Details |
| A04628 | 33557653 | Expert Rev Gastroenterol Hepatol | Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease. | 2021 | Details |
| A04629 | 33557355 | Life (Basel) | Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits. | 2021 | Details |
| A04630 | 33557317 | Metabolites | A Study of Blood Fatty Acids Profile in Hyperlipidemic and Normolipidemic Subjects in Association with Common PNPLA3 and ABCB1 Polymorphisms. | 2021 | Details |
| A04631 | 33557304 | Antioxidants (Basel) | Oxidized High-Density Lipoprotein Shows a Stepwise Increase as Fibrosis Progresses in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04632 | 33557031 | Life (Basel) | Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap. | 2021 | Details |
| A04633 | 33556870 | Biomed Pharmacother | New insight and potential therapy for NAFLD: CYP2E1 and flavonoids. | 2021 | Details |
| A04634 | 33556624 | Biochim Biophys Acta Gene Regul Mech | Aberrant gene expression induced by a high fat diet is linked to H3K9 acetylation in the promoter-proximal region. | 2021 | Details |
| A04635 | 33556256 | Scand J Gastroenterol | Serum levels of endotrophin are associated with nonalcoholic steatohepatitis. | 2021 | Details |
| A04636 | 33555523 | J Gastrointest Surg | Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARα) Signaling to Significantly Reduce Liver Fat Content. | 2021 | Details |
| A04637 | 33555168 | Clin Transl Gastroenterol | Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation. | 2021 | Details |
| A04638 | 33555112 | Liver Int | Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice. | 2021 | Details |
| A04639 | 33554867 | Mol Ther | Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. | 2020 | Details |
| A04640 | 33554350 | Hepatology | The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident-Memory T Cells in Autoimmune Hepatitis. | 2021 | Details |
| A04641 | 33554097 | JHEP Rep | Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction. | 2020 | Details |
| A04642 | 33554072 | iScience | Impact of liver-specific GLUT8 silencing on fructose-induced inflammation and omega oxidation. | 2021 | Details |
| A04643 | 33553970 | Hepatol Commun | Human Nonalcoholic Steatohepatitis on a Chip. | 2020 | Details |
| A04644 | 33553966 | Hepatol Commun | Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting. | 2020 | Details |
| A04645 | 33553660 | JGH Open | Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study. | 2020 | Details |
| A04646 | 33553659 | JGH Open | Meta-analysis of the effects of sodium glucose cotransporter 2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes. | 2020 | Details |
| A04647 | 33552480 | Clin Liver Dis (Hoboken) | The Influence of the Microbiome on NAFLD and NASH. | 2021 | Details |
| A04648 | 33552479 | Clin Liver Dis (Hoboken) | The Role of Life Style Modifications in Comprehensive Non-Alcoholic Fatty Liver Disease Treatment. | 2021 | Details |
| A04649 | 33552218 | Evid Based Complement Alternat Med | Probiotics as a Complementary Therapy for Management of Obesity: A Systematic Review. | 2021 | Details |
| A04650 | 33551355 | Dig Liver Dis | Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19. | 2021 | Details |
| A04651 | 33551215 | Clin Nutr | Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A04652 | 33550706 | Liver Int | Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial. | 2021 | Details |
| A04653 | 33550587 | Hepatology | Heterogeneity of HSCs in a Mouse Model of NASH. | 2021 | Details |
| A04654 | 33550112 | Redox Biol | Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase. | 2021 | Details |
| A04655 | 33550014 | Comput Biol Med | Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. | 2021 | Details |
| A04656 | 33549920 | Clin Imaging | Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography. | 2021 | Details |
| A04657 | 33549735 | Ann Hepatol | Hepatic steatosis and respiratory diseases: a new panorama. | 2021 | Details |
| A04658 | 33549451 | Nutr Metab Cardiovasc Dis | Apolipoprotein A5 controls fructose-induced metabolic dysregulation in mice. | 2020 | Details |
| A04659 | 33549441 | Nutr Metab Cardiovasc Dis | Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience. | 2020 | Details |
| A04660 | 33548473 | J Nutr Biochem | Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice. | 2021 | Details |
| A04661 | 33548472 | J Nutr Biochem | Dietary lycopene attenuates cigarette smoke-promoted nonalcoholic steatohepatitis by preventing suppression of antioxidant enzymes in ferrets. | 2021 | Details |
| A04662 | 33548387 | J Hepatol | FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease. | 2021 | Details |
| A04663 | 33548123 | J Gastrointestin Liver Dis | Vegan Diet Advice Might Benefit Liver Enzymes in Nonalcoholic Fatty Liver Disease: an Open Observational Pilot Study. | 2021 | Details |
| A04664 | 33548031 | Hepatol Int | How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? | 2021 | Details |
| A04665 | 33546922 | Trends Cell Biol | Lipid Droplet Contact Sites in Health and Disease. | 2021 | Details |
| A04667 | 33546405 | Nutrients | Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice. | 2021 | Details |
| A04668 | 33546191 | Biomedicines | Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. | 2021 | Details |
| A04669 | 33546175 | Biology (Basel) | Degree Adjusted Large-Scale Network Analysis Reveals Novel Putative Metabolic Disease Genes. | 2021 | Details |
| A04670 | 33546130 | Nutrients | Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04671 | 33546051 | Medicine (Baltimore) | Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence: A protocol for a Bayesian network meta analysis. | 2021 | Details |
| A04673 | 33545430 | Cell Mol Gastroenterol Hepatol | Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH. | 2021 | Details |
| A04674 | 33545428 | Cell Mol Gastroenterol Hepatol | SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04675 | 33545391 | Mol Metab | Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH. | 2021 | Details |
| A04676 | 33545191 | J Pediatr | Hepatic Steatosis is Negatively Associated with Bone Mineral Density in Children. | 2021 | Details |
| A04677 | 33545051 | Cell Metab | Metabolic stress drives sympathetic neuropathy within the liver. | 2021 | Details |
| A04678 | 33544906 | Hepatology | De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations. | 2021 | Details |
| A04679 | 33544802 | Rom J Morphol Embryol | The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients. | 2021 | Details |
| A04681 | 33544313 | Hepatol Int | Regression of portal hypertension: underlying mechanisms and therapeutic strategies. | 2021 | Details |
| A04682 | 33544287 | Curr Diab Rep | Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications. | 2021 | Details |
| A04683 | 33544129 | Clin Infect Dis | Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus. | 2021 | Details |
| A04684 | 33542919 | Biomed Res Int | Protective Effects of Iridoid Glycoside from Corni Fructus on Type 2 Diabetes with Nonalcoholic Fatty Liver in Mice. | 2021 | Details |
| A04685 | 33542911 | Can J Gastroenterol Hepatol | Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice. | 2021 | Details |
| A04686 | 33542909 | Can J Gastroenterol Hepatol | Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis. | 2021 | Details |
| A04687 | 33542014 | BMJ Case Rep | Accidentally discovered high INR in pregnancy unmasks an inherited factor VII (FVII) deficiency that is paradoxically associated with thrombotic tendency. | 2021 | Details |
| A04688 | 33541866 | Gut | Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? | 2021 | Details |
| A04689 | 33541789 | Obes Res Clin Pract | Roles and mechanisms of NRG1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG1 modulates NAFLD through ErbB3 signaling). | 2021 | Details |
| A04690 | 33541129 | Exp Biol Med (Maywood) | Effect of vitamin D3 supplementation on hepatic lipid dysregulation associated with autophagy regulatory AMPK/Akt-mTOR signaling in type 2 diabetic mice. | 2021 | Details |
| A04691 | 33541087 | Chin Clin Oncol | Epidemiology, mutational landscape and staging of hepatocellular carcinoma. | 2021 | Details |
| A04692 | 33539004 | Hepatol Int | The metabolic profiles and body composition of lean metabolic associated fatty liver disease. | 2021 | Details |
| A04693 | 33538526 | Gastroenterol Nurs | Gut Microbiome and Nonalcoholic Fatty Liver Disease (NAFLD): Implications for Nursing Care of Individuals Living With Chronic Metabolic Diseases. | 2021 | Details |
| A04694 | 33537464 | Biochem Biophys Rep | A high methionine and low folate diet alters glucose homeostasis and gut microbiome. | 2021 | Details |
| A04695 | 33537324 | Front Med (Lausanne) | Association Between Anxiety and Depression and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04696 | 33536590 | Sci Rep | The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs. | 2021 | Details |
| A04697 | 33536476 | Sci Rep | Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A04698 | 33536442 | Sci Rep | Clinical implications of renin-angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A04699 | 33536048 | Nutr Metab (Lond) | Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial. | 2021 | Details |
| A04700 | 33535836 | Expert Rev Clin Pharmacol | An update on drug development for the treatment of nonalcoholic fatty liver disease - from ongoing clinical trials to future therapy. | 2021 | Details |
| A04701 | 33535679 | J Clin Med | External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study. | 2021 | Details |
| A04702 | 33535220 | J Vasc Res | Pyridoxamine and Caloric Restriction Improve Metabolic and Microcirculatory Abnormalities in Rats with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04703 | 33535211 | Dig Dis | NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea. | 2021 | Details |